State Of Wyoming Adc Therapeutics Sa Transaction History
State Of Wyoming
- $754 Million
- Q4 2024
A detailed history of State Of Wyoming transactions in Adc Therapeutics Sa stock. As of the latest transaction made, State Of Wyoming holds 8,267 shares of ADCT stock, worth $13,227. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,267Holding current value
$13,227% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding ADCT
# of Institutions
85Shares Held
53.5MCall Options Held
28KPut Options Held
60.4K-
Redmile Group, LLC San Francisco, CA15.7MShares$25.1 Million2.44% of portfolio
-
Prosight Management, LP Dallas, TX9.52MShares$15.2 Million5.62% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.97MShares$9.55 Million0.32% of portfolio
-
Morgan Stanley New York, NY3.96MShares$6.33 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$5.69 Million0.0% of portfolio
About ADC Therapeutics SA
- Ticker ADCT
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,645,296
- Market Cap $124M
- Description
- ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...